Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • M.D., University of Southampton (United Kingdom) 2007
  • B.M., University of Southampton (United Kingdom) 1989
• 

  Previous Appointments & Affiliations

  • Associate Professor of Medicine, Medicine, Gastroenterology, Medicine 2014 - 2015
  • Associate Professor of Medicine, Medicine, Gastroenterology, Medicine 2012 - 2014
  • Assistant Professor of Medicine, Medicine, Gastroenterology, Medicine 2005 - 2012
  • Associate in the Department of Medicine, Medicine, Gastroenterology, Medicine 2003 - 2004
• Recognition
• 

  Awards & Honors

  • Clinical and Translational Research Award. American Association for the Study of Liver Diseases. 2004
• Research
• 

  Selected Grants

  • HBV Clinical Research Network Site Application_Subcontract to UNC awarded by University of North Carolina - Chapel Hill 2008 - 2015
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Nielsen, M. J., G. E. Dolman, R. Harris, P. Frederiksen, J. Chalmers, J. I. Grove, W. L. Irving, et al. “PRO-C3 is a predictor of clinical outcomes in distinct cohorts of patients with advanced liver disease (Accepted).” Jhep Reports 5, no. 6 (June 1, 2023). https://doi.org/10.1016/j.jhepr.2023.100743.
       Full Text
    • Patmore, Lesley A., Warshan K. Katwaroe, Daniel van der Spek, Hannah S. J. Choi, Keyur Patel, Sylvia Brakenhoff, Adriaan J. van der Meer, et al. “Association Between the Presence of Metabolic Comorbidities and Liver-Related Events in Patients With Chronic Hepatitis B.” Clin Gastroenterol Hepatol, March 31, 2023. https://doi.org/10.1016/j.cgh.2023.03.024.
       Full Text  Link to Item
    • Kleiner, David E., Mauricio Lisker-Melman, Abdus S. Wahed, Atul K. Bhan, Michael A. Nalesnik, Eun-Young K. Choi, Kelsey K. Leonard, et al. “Immunostaining for hepatitis B viral antigens in liver: Association with clinical, biochemical, and virologic features of disease.” J Gastroenterol Hepatol, March 8, 2023. https://doi.org/10.1111/jgh.16167.
       Full Text  Link to Item
    • Karnam, R. S., A. Azhie, C. Yang, A. Rogalsky, S. Chen, W. Xu, K. Patel, et al. “Impact of living donor liver transplantation on long-term cardiometabolic and graft outcomes in cirrhosis due to nonalcoholic steatohepatitis.” Clinical Transplantation, January 1, 2023. https://doi.org/10.1111/ctr.15008.
       Full Text
    • Xu, Jun, Ya Wang, Mina Khoshdeli, Matt Peach, Jen-Chieh Chuang, Julie Lin, Wen-Wei Tsai, et al. “IL-31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases and is farnesoid X receptor responsive in NASH.” Hepatology 77, no. 1 (January 1, 2023): 20–32. https://doi.org/10.1002/hep.32599.
       Full Text  Link to Item
    • Perrillo, Robert, Hsing-Hua S. Lin, Kathleen B. Schwarz, Philip Rosenthal, Mauricio Lisker-Melman, Raymond T. Chung, Ludmila Prokunina-Olsson, Gavin Cloherty, Jordan Feld, and Jordan Hepatitis B Research Network (HBRN). “Changes in serum hepatitis B surface and e antigen, interferon-inducible protein 10, and aminotransferase levels during combination therapy of immune-tolerant chronic hepatitis B.” Hepatology 76, no. 3 (September 2022): 775–87. https://doi.org/10.1002/hep.32400.
       Full Text  Link to Item
    • Minich, A., F. A. Q. Arisar, N. U. S. Shaikh, L. Herman, A. Azhie, A. Orchanian-Cheff, K. Patel, S. Keshavarzi, and M. Bhat. “Predictors of patient survival following liver transplant in non-alcoholic steatohepatitis: A systematic review and meta-analysis.” Eclinicalmedicine 50 (August 1, 2022). https://doi.org/10.1016/j.eclinm.2022.101534.
       Full Text
    • Pehrsson, Martin, Tina Manon-Jensen, Shu Sun, Ida F. Villesen, Helena Castañé, Jorge Joven, Keyur Patel, et al. “An MMP-degraded and cross-linked fragment of type III collagen as a non-invasive biomarker of hepatic fibrosis resolution.” Liver Int 42, no. 7 (July 2022): 1605–17. https://doi.org/10.1111/liv.15270.
       Full Text  Link to Item
    • Chahal, Daljeet, Divya Sharma, Sareh Keshavarzi, Fakhar Ali Qazi Arisar, Keyur Patel, Wei Xu, and Mamatha Bhat. “Distinctive clinical and genetic features of lean vs overweight fatty liver disease using the UK Biobank.” Hepatol Int 16, no. 2 (April 2022): 325–36. https://doi.org/10.1007/s12072-022-10304-z.
       Full Text  Link to Item
    • Sarvestany, Soren Sabet, Jeffrey C. Kwong, Amirhossein Azhie, Victor Dong, Orlando Cerocchi, Ahmed Fuad Ali, Ravikiran S. Karnam, et al. “Development and validation of an ensemble machine learning framework for detection of all-cause advanced hepatic fibrosis: a retrospective cohort study.” Lancet Digit Health 4, no. 3 (March 2022): e188–99. https://doi.org/10.1016/S2589-7500(21)00270-3.
       Full Text  Link to Item
    • Sharma, Divya, Neta Gotlieb, Michael E. Farkouh, Keyur Patel, Wei Xu, and Mamatha Bhat. “Machine Learning Approach to Classify Cardiovascular Disease in Patients With Nonalcoholic Fatty Liver Disease in the UK Biobank Cohort.” J Am Heart Assoc 11, no. 1 (January 4, 2022): e022576. https://doi.org/10.1161/JAHA.121.022576.
       Full Text  Link to Item
    • Sebastiani, G., K. Patel, V. Ratziu, J. J. Feld, B. A. Neuschwander-Tetri, M. Pinzani, S. Petta, et al. “Current considerations for clinical management and care of non-alcoholic fatty liver disease: Insights from the 1st International Workshop of the Canadian NASH Network (CanNASH).” Canadian Liver Journal 5, no. 1 (January 1, 2022): 61–90. https://doi.org/10.3138/canlivj-2021-0030.
       Full Text
    • Leung, Kristel K., Audrey Kim, Bettina E. Hansen, Les Lilly, Nazia Selzner, Keyur Patel, Mamatha Bhat, Gideon M. Hirschfield, and Zita Galvin. “The Impact of Primary Liver Disease and Social Determinants in a Mixed Donor Liver Transplant Program: A Single-Center Analysis.” Liver Transpl 27, no. 12 (December 2021): 1733–46. https://doi.org/10.1002/lt.26195.
       Full Text  Link to Item
    • Kosick, Heather Mary-Kathleen, Aline Keyrouz, Oyedele Adeyi, Giada Sebastiani, and Keyur Patel. “A Stepwise Algorithmic Approach and External Validation Study for Noninvasive Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease.” Dig Dis Sci 66, no. 11 (November 2021): 4046–57. https://doi.org/10.1007/s10620-020-06748-8.
       Full Text  Link to Item
    • Lee, William M., Wendy C. King, Harry L. A. Janssen, Marc G. Ghany, Robert J. Fontana, Michael Fried, Richard K. Sterling, et al. “Hepatitis B e antigen loss in adults and children with chronic hepatitis B living in North America: A prospective cohort study.” J Viral Hepat 28, no. 11 (November 2021): 1526–38. https://doi.org/10.1111/jvh.13591.
       Full Text  Link to Item
    • Kleef, L. A. van, H. S. J. Choi, W. P. Brouwer, B. E. Hansen, K. Patel, R. A. de Man, H. L. A. Janssen, R. J. de Knegt, and M. J. Sonneveld. “Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B.” Jhep Reports 3, no. 5 (October 1, 2021). https://doi.org/10.1016/j.jhepr.2021.100350.
       Full Text
    • Moini, Maryam, Fernanda Onofrio, Bettina E. Hansen, Oyedele Adeyi, Korosh Khalili, and Keyur Patel. “Combination of FIB-4 with ultrasound surface nodularity or elastography as predictors of histologic advanced liver fibrosis in chronic liver disease.” Sci Rep 11, no. 1 (September 29, 2021): 19275. https://doi.org/10.1038/s41598-021-98776-1.
       Full Text  Link to Item
    • Alhinai, Alshaima, Keyur Patel, Vivian A. Fonseca, and Giada Sebastiani. “Non-invasive diagnosis of nonalcoholic fatty liver disease in patients with type 2 diabetes.” J Diabetes Complications 35, no. 9 (September 2021): 107978. https://doi.org/10.1016/j.jdiacomp.2021.107978.
       Full Text  Link to Item
    • Cooper, Stewart L., Wendy C. King, Douglas B. Mogul, Marc G. Ghany, Kathleen B. Schwarz, and Kathleen B. Hepatitis B Research Network (HBRN). “Clinical significance of quantitative e antigen in a cohort of hepatitis B virus-infected children and adults in North America.” J Viral Hepat 28, no. 7 (July 2021): 1042–56. https://doi.org/10.1111/jvh.13520.
       Full Text  Link to Item
    • Lok, Anna S., Robert Perrillo, Christina M. Lalama, Michael W. Fried, Steven H. Belle, Marc G. Ghany, Mandana Khalili, et al. “Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy.” Hepatology 73, no. 6 (June 2021): 2124–40. https://doi.org/10.1002/hep.31554.
       Full Text  Link to Item
    • Sebastiani, G., A. Ramji, M. G. Swain, and K. Patel. “A canadian survey on knowledge of non-alcoholic fatty liver disease among physicians.” Canadian Liver Journal 4, no. 2 (March 1, 2021): 82–92. https://doi.org/10.3138/canlivj-2020-0033.
       Full Text
    • Loomba, Rohit, Mazen Noureddin, Kris V. Kowdley, Anita Kohli, Aasim Sheikh, Guy Neff, Bal Raj Bhandari, et al. “Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH.” Hepatology 73, no. 2 (February 2021): 625–43. https://doi.org/10.1002/hep.31622.
       Full Text  Link to Item
    • Cervo, Adriana, Mohamed Shengir, Keyur Patel, and Giada Sebastiani. “NASH in HIV.” Curr Hiv/Aids Rep 17, no. 6 (December 2020): 601–14. https://doi.org/10.1007/s11904-020-00531-0.
       Full Text  Link to Item
    • Patel, Keyur, Chuhan Chung, and Robert P. Myers. “Reply.” Hepatology 72, no. 6 (December 2020): 2241–42. https://doi.org/10.1002/hep.31402.
       Full Text  Link to Item
    • Naggie, Susanna, Sam Lusk, J Will Thompson, Meredith Mock, Cynthia Moylan, Joseph E. Lucas, Laura Dubois, Lisa St John-Williams, M Arthur Moseley, and Keyur Patel. “Metabolomic Signature as a Predictor of Liver Disease Events in Patients With HIV/HCV Coinfection.” J Infect Dis 222, no. 12 (November 13, 2020): 2012–20. https://doi.org/10.1093/infdis/jiaa316.
       Full Text  Link to Item
    • Patel, Keyur, Ryan Lamm, Peter Altshuler, Hien Dang, and Ashesh P. Shah. “Hepatocellular Carcinoma-The Influence of Immunoanatomy and the Role of Immunotherapy.” Int J Mol Sci 21, no. 18 (September 15, 2020). https://doi.org/10.3390/ijms21186757.
       Full Text  Link to Item
    • Barry, A. E., R. Baldeosingh, R. Lamm, K. Patel, K. Zhang, D. A. Dominguez, K. J. Kirton, A. P. Shah, and H. Dang. “Hepatic Stellate Cells and Hepatocarcinogenesis.” Frontiers in Cell and Developmental Biology 8 (August 5, 2020). https://doi.org/10.3389/fcell.2020.00709.
       Full Text
    • Patel, Keyur, Stephen A. Harrison, Magdy Elkhashab, James F. Trotter, Robert Herring, Sergio E. Rojter, Zeid Kayali, et al. “Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial.” Hepatology 72, no. 1 (July 2020): 58–71. https://doi.org/10.1002/hep.31205.
       Full Text  Link to Item
    • Patel, K., and G. Sebastiani. “Limitations of non-invasive tests for assessment of liver fibrosis.” Jhep Reports 2, no. 2 (April 1, 2020). https://doi.org/10.1016/j.jhepr.2020.100067.
       Full Text
    • Choi, Hannah S. J., Willem P. Brouwer, Bettina E. Hansen, Harry L. A. Janssen, and Keyur Patel. “Reply.” Hepatology 71, no. 2 (February 2020): 769. https://doi.org/10.1002/hep.30980.
       Full Text  Link to Item
    • Choi, Hannah S. J., Willem P. Brouwer, Wayel M. R. Zanjir, Robert A. de Man, Jordan J. Feld, Bettina E. Hansen, Harry L. A. Janssen, and Keyur Patel. “Nonalcoholic Steatohepatitis Is Associated With Liver-Related Outcomes and All-Cause Mortality in Chronic Hepatitis B.” Hepatology 71, no. 2 (February 2020): 539–48. https://doi.org/10.1002/hep.30857.
       Full Text  Link to Item
    • Neil Guha, Indra, and Keyur Patel. “Editorial: blood biomarkers for advanced liver fibrosis in non-alcoholic fatty liver disease-not a simple choice?” Aliment Pharmacol Ther 51, no. 1 (January 2020): 179–80. https://doi.org/10.1111/apt.15578.
       Full Text  Link to Item
    • Swain, Mark G., Alnoor Ramji, Keyur Patel, Giada Sebastiani, Abdel Aziz Shaheen, Edward Tam, Paul Marotta, et al. “Burden of nonalcoholic fatty liver disease in Canada, 2019-2030: a modelling study.” Cmaj Open 8, no. 2 (2020): E429–36. https://doi.org/10.9778/cmajo.20190212.
       Full Text  Link to Item
    • Tam, E., J. Tremblay, C. Fraser, B. Conway, A. Ramji, S. Borgia, K. Tsoi, et al. “The z-profile study: A multicenter, retrospective cohort study to assess the real-world use and effectiveness of elbasvir/grazoprevir in canadian adult patients with chronic hepatitis c.” Canadian Liver Journal 3, no. 3 (January 1, 2020): 251–62. https://doi.org/10.3138/canlivj-2019-0029.
       Full Text
    • Brahmania, Mayur, Manuel Lombardero, Bettina E. Hansen, Norah A. Terrault, Anna S. Lok, Robert P. Perrillo, Steven H. Belle, et al. “Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection.” Clin Gastroenterol Hepatol 17, no. 12 (November 2019): 2541-2551.e2. https://doi.org/10.1016/j.cgh.2019.02.005.
       Full Text  Link to Item
    • Di Bisceglie, Adrian M., Wendy C. King, Mauricio Lisker-Melman, Mandana Khalili, Steven H. Belle, Jordan J. Feld, Marc G. Ghany, et al. “Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B.” J Viral Hepat 26, no. 7 (July 2019): 856–65. https://doi.org/10.1111/jvh.13104.
       Full Text  Link to Item
    • Galvin, Zita, Keyur Patel, and Mamatha Bhat. “Reply.” Liver Transpl 25, no. 6 (June 2019): 969–70. https://doi.org/10.1002/lt.25465.
       Full Text  Link to Item
    • Naggie, Susanna, Meredith Clement, Sam Lusk, Anu Osinusi, Tiffany Himmel, Joseph E. Lucas, Will J. Thompson, et al. “Using Stepwise Pharmacogenomics and Proteomics to Predict Hepatitis C Treatment Response in Difficult to Treat Patient Populations.” Proteomics Clin Appl 13, no. 3 (May 2019): e1800006. https://doi.org/10.1002/prca.201800006.
       Full Text  Link to Item
    • Ajmera, Veeral, Hailiang Huang, Doan Dao, Jordan J. Feld, Daryl T. Lau, Keyur Patel, Jody A. Rule, Mark Daly, William M. Lee, and Raymond T. Chung. “Host Genetic Variant in CXCL16 May Be Associated With Hepatitis B Virus-Related Acute Liver Failure.” Cell Mol Gastroenterol Hepatol 7, no. 2 (2019): 477-479.e4. https://doi.org/10.1016/j.jcmgh.2018.09.018.
       Full Text  Link to Item
    • Galvin, Zita, Ramraj Rajakumar, Emily Chen, Oyedele Adeyi, Markus Selzner, David Grant, Gonzalo Sapisochin, et al. “Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis.” Liver Transpl 25, no. 1 (January 2019): 56–67. https://doi.org/10.1002/lt.25338.
       Full Text  Link to Item
    • Cunningham, Morven E., Gilda Parastandeh-Chehr, Orlando Cerocchi, David K. Wong, and Keyur Patel. “Noninvasive Predictors of High-Risk Varices in Patients with Non-Cirrhotic Portal Hypertension.” Can J Gastroenterol Hepatol 2019 (2019): 1808797. https://doi.org/10.1155/2019/1808797.
       Full Text  Link to Item
    • Karsdal, Morten A., Sara T. Hjuler, Yi Luo, Daniel G. K. Rasmussen, Mette J. Nielsen, Signe Holm Nielsen, Diana J. Leeming, et al. “Assessment of liver fibrosis progression and regression by a serological collagen turnover profile.” Am J Physiol Gastrointest Liver Physiol 316, no. 1 (January 1, 2019): G25–31. https://doi.org/10.1152/ajpgi.00158.2018.
       Full Text  Link to Item
    • Glass, Oliver, Ricardo Henao, Keyur Patel, Cynthia D. Guy, Hans J. Gruss, Wing-Kin Syn, Cynthia A. Moylan, et al. “Serum Interleukin-8, Osteopontin, and Monocyte Chemoattractant Protein 1 Are Associated With Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.” Hepatol Commun 2, no. 11 (November 2018): 1344–55. https://doi.org/10.1002/hep4.1237.
       Full Text  Link to Item
    • Kotha, Sreelakshmi, ShuetFong Neong, and Keyur Patel. “Serum biomarkers for diagnosis and monitoring viral hepatitis and hepatocellular carcinoma.” Expert Rev Mol Diagn 18, no. 8 (August 2018): 713–22. https://doi.org/10.1080/14737159.2018.1496020.
       Full Text  Link to Item
    • Younossi, Zobair M., Maria Stepanova, Tarik Asselah, Graham Foster, Keyur Patel, Norbert Bräu, Mark Swain, et al. “Hepatitis C in Patients With Minimal or No Hepatic Fibrosis: The Impact of Treatment and Sustained Virologic Response on Patient-Reported Outcomes.” Clin Infect Dis 66, no. 11 (May 17, 2018): 1742–50. https://doi.org/10.1093/cid/cix1106.
       Full Text  Link to Item
    • Lok, A. S., L. Ganova-Raeva, Y. Cloonan, L. Punkova, H. -. H. S. Lin, W. M. Lee, M. G. Ghany, and M. G. Hepatitis B Research Network (HBRN). “Prevalence of hepatitis B antiviral drug resistance variants in North American patients with chronic hepatitis B not receiving antiviral treatment.” J Viral Hepat 24, no. 11 (November 2017): 1032–42. https://doi.org/10.1111/jvh.12732.
       Full Text  Link to Item
    • Jacobson, Ira M., Mary K. Washington, Maria Buti, Alexander Thompson, Nezam Afdhal, Robert Flisiak, Ulus Salih Akarca, et al. “Factors Associated With Persistent Increase in Level of Alanine Aminotransferase in Patients With Chronic Hepatitis B Receiving Oral Antiviral Therapy.” Clin Gastroenterol Hepatol 15, no. 7 (July 2017): 1087-1094.e2. https://doi.org/10.1016/j.cgh.2017.01.032.
       Full Text  Link to Item
    • Rathod, D. M., K. R. Patel, H. N. Mistri, A. G. Jangid, P. S. Shrivastav, and M. Sanyal. “An improved LC-MS/MS method for the quantification of alverine and para hydroxy alverine in human plasma for a bioequivalence study^☆.” Journal of Pharmaceutical Analysis 7, no. 2 (April 1, 2017): 95–102. https://doi.org/10.1016/j.jpha.2016.11.003.
       Full Text
    • Di Bisceglie, A. M., M. Lombardero, J. Teckman, L. Roberts, H. L. A. Janssen, S. H. Belle, J. H. Hoofnagle, and J. H. Hepatitis B Research Network (HBRN). “Determination of hepatitis B phenotype using biochemical and serological markers.” J Viral Hepat 24, no. 4 (April 2017): 320–29. https://doi.org/10.1111/jvh.12643.
       Full Text  Link to Item
    • Rathod, D. M., K. R. Patel, H. N. Mistri, A. G. Jangid, P. S. Shrivastav, and M. Sanyal. “Simultaneous analysis of allopurinol and oxypurinol using a validated liquid chromatography–tandem mass spectrometry method in human plasma.” Journal of Pharmaceutical Analysis 7, no. 1 (February 1, 2017): 56–62. https://doi.org/10.1016/j.jpha.2016.05.005.
       Full Text
    • Buse, John B., M Angelyn Bethel, Jennifer B. Green, Susanna R. Stevens, Yuliya Lokhnygina, Pablo Aschner, Carlos Raffo Grado, et al. “Pancreatic Safety of Sitagliptin in the TECOS Study.” Diabetes Care 40, no. 2 (February 2017): 164–70. https://doi.org/10.2337/dc15-2780.
       Full Text  Link to Item
    • Chan, Austin, Keyur Patel, and Susanna Naggie. “Genotype 3 Infection: The Last Stand of Hepatitis C Virus.” Drugs 77, no. 2 (February 2017): 131–44. https://doi.org/10.1007/s40265-016-0685-x.
       Full Text  Link to Item
    • Baciu, Cristina, Elisa Pasini, Marc Angeli, Katherine Schwenger, Jenifar Afrin, Atul Humar, Sandra Fischer, Keyur Patel, Johane Allard, and Mamatha Bhat. “Systematic integrative analysis of gene expression identifies HNF4A as the central gene in pathogenesis of non-alcoholic steatohepatitis.” Plos One 12, no. 12 (2017): e0189223. https://doi.org/10.1371/journal.pone.0189223.
       Full Text  Link to Item
    • Karsdal, Morten A., Kim Henriksen, Mette Juul Nielsen, Inger Byrjalsen, Diana J. Leeming, Stephen Gardner, Zachary Goodman, et al. “Fibrogenesis assessed by serological type III collagen formation identifies patients with progressive liver fibrosis and responders to a potential antifibrotic therapy.” Am J Physiol Gastrointest Liver Physiol 311, no. 6 (December 1, 2016): G1009–17. https://doi.org/10.1152/ajpgi.00283.2016.
       Full Text  Link to Item
    • Younossi, Zobair M., Maria Stepanova, Mark Sulkowski, Graham R. Foster, Nancy Reau, Alessandra Mangia, Keyur Patel, et al. “Ribavirin-Free Regimen With Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and -3 Clinical Trials.” Clin Infect Dis 63, no. 8 (October 15, 2016): 1042–48. https://doi.org/10.1093/cid/ciw496.
       Full Text  Link to Item
    • Matta, Bassem, Tzu-Hao Lee, and Keyur Patel. “Use of Non-invasive Testing to Stage Liver Fibrosis in Patients with HIV.” Curr Hiv/Aids Rep 13, no. 5 (October 2016): 279–88. https://doi.org/10.1007/s11904-016-0329-5.
       Full Text  Link to Item
    • Wong, Tammy C., Audrey Lan, Jennifer J. Kiser, Peter L. Anderson, Keyur Patel, Hans Tillman, and Susanna Naggie. “Novel quantification of tenofovir disoproxil fumarate adherence in human immunodeficiency virus/hepatitis B coinfected patients with incomplete hepatitis B virus viral suppression.” Hepatology 64, no. 3 (September 2016): 999–1000. https://doi.org/10.1002/hep.28461.
       Full Text  Link to Item
    • Rathod, D. M., K. R. Patel, H. N. Mistri, A. G. Jangid, P. S. Shrivastav, and M. Sanyal. “Liquid chromatography–tandem mass spectrometry method for simultaneous determination of albendazole and albendazole sulfoxide in human plasma for bioequivalence studies.” Journal of Pharmaceutical Analysis 6, no. 4 (August 1, 2016): 226–34. https://doi.org/10.1016/j.jpha.2016.02.002.
       Full Text
    • Bedossa, Pierre, and Keyur Patel. “Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease.” Gastroenterology 150, no. 8 (June 2016): 1811-1822.e4. https://doi.org/10.1053/j.gastro.2016.03.008.
       Full Text  Link to Item
    • Rathod, Dhiraj M., Keyur R. Patel, Hiren N. Mistri, Arvind G. Jangid, Pranav S. Shrivastav, and Mallika Sanyal. “Application of an LC-MS/MS method for reliable determination of amodiaquine, N-desethylamodiaquine, artesunate and dihydroartemisinin in human plasma for a bioequivalence study in healthy Indian subjects.” J Pharm Biomed Anal 124 (May 30, 2016): 67–78. https://doi.org/10.1016/j.jpba.2016.02.021.
       Full Text  Link to Item
    • Patel, K., H. L. Tillmann, B. Matta, M. J. Sheridan, S. D. Gardner, N. A. Shackel, J. G. McHutchison, and Z. D. Goodman. “Longitudinal assessment of hepatitis C fibrosis progression by collagen and smooth muscle actin morphometry in comparison to serum markers.” Aliment Pharmacol Ther 43, no. 3 (February 2016): 356–63. https://doi.org/10.1111/apt.13471.
       Full Text  Link to Item
    • Tian, Xu, Keyur Patel, John R. Ridpath, Youjun Chen, Yi-Hui Zhou, Dayna Neo, Jean Clement, et al. “Homologous Recombination and Translesion DNA Synthesis Play Critical Roles on Tolerating DNA Damage Caused by Trace Levels of Hexavalent Chromium.” Plos One 11, no. 12 (2016): e0167503. https://doi.org/10.1371/journal.pone.0167503.
       Full Text  Link to Item
    • Younossi, Zobair M., Maria Stepanova, Michael Estep, Francesco Negro, Paul J. Clark, Sharon Hunt, Qinghua Song, et al. “Dysregulation of distal cholesterol biosynthesis in association with relapse and advanced disease in CHC genotype 2 and 3 treated with sofosbuvir and ribavirin.” J Hepatol 64, no. 1 (January 2016): 29–36. https://doi.org/10.1016/j.jhep.2015.08.027.
       Full Text  Link to Item
    • Foster, Graham R., Nezam Afdhal, Stuart K. Roberts, Norbert Bräu, Edward J. Gane, Stephen Pianko, Eric Lawitz, et al. “Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection.” N Engl J Med 373, no. 27 (December 31, 2015): 2608–17. https://doi.org/10.1056/NEJMoa1512612.
       Full Text  Link to Item
    • Khalili, Mandana, Manuel Lombardero, Raymond T. Chung, Norah A. Terrault, Marc G. Ghany, W Ray Kim, Daryl Lau, et al. “Diabetes and prediabetes in patients with hepatitis B residing in North America.” Hepatology 62, no. 5 (November 2015): 1364–74. https://doi.org/10.1002/hep.28110.
       Full Text  Link to Item
    • Lee, Tzu-Hao, Bassem Matta, Bernard D. King, Michael R. Hodges, Hans L. Tillmann, and Keyur Patel. “MicroRNA-122 associates with serum apolipoprotein B but not liver fibrosis markers in CHC genotype 1 infection.” J Med Virol 87, no. 10 (October 2015): 1722–26. https://doi.org/10.1002/jmv.24230.
       Full Text  Link to Item
    • Bedossa, Pierre, Keyur Patel, and Laurent Castera. “Histologic and noninvasive estimates of liver fibrosis.” Clin Liver Dis (Hoboken) 6, no. 1 (July 2015): 5–8. https://doi.org/10.1002/cld.481.
       Full Text  Link to Item
    • Patel, Keyur, Pierre Bedossa, and Laurent Castera. “Diagnosis of liver fibrosis: present and future.” Semin Liver Dis 35, no. 2 (May 2015): 166–83. https://doi.org/10.1055/s-0035-1550059.
       Full Text  Link to Item
    • Afdhal, Nezam H., Bruce R. Bacon, Keyur Patel, Eric J. Lawitz, Stuart C. Gordon, David R. Nelson, Tracy L. Challies, et al. “Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter study.” Clin Gastroenterol Hepatol 13, no. 4 (April 2015): 772-9.e1-3. https://doi.org/10.1016/j.cgh.2014.12.014.
       Full Text  Link to Item
    • Naggie, Susanna, Keyur Patel, Lan-Yan Yang, Shein-Chung Chow, Victoria Johnson, John R. Guyton, Andrew J. Muir, Mark Sulkowski, and Charles Hicks. “Antiretroviral Effects on Host Lipoproteins Are Associated With Changes in Hepatitis C Virus (HCV) RNA Levels in Human Immunodeficiency Virus/HCV Coinfected Individuals.” Open Forum Infect Dis 2, no. 2 (April 2015): ofv066. https://doi.org/10.1093/ofid/ofv066.
       Full Text  Open Access Copy  Link to Item
    • Meissner, Eric G., Yu-Jin Lee, Anu Osinusi, Zayani Sims, Jing Qin, Dan Sturdevant, John McHutchison, et al. “Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1-infected patients.” Hepatology 61, no. 3 (March 2015): 790–801. https://doi.org/10.1002/hep.27424.
       Full Text  Link to Item
    • Nielsen, Mette J., Sanne S. Veidal, Morten A. Karsdal, Diana J. Ørsnes-Leeming, Ben Vainer, Stephen D. Gardner, Robert Hamatake, Zachary D. Goodman, Detlef Schuppan, and Keyur Patel. “Plasma Pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C.” Liver Int 35, no. 2 (February 2015): 429–37. https://doi.org/10.1111/liv.12700.
       Full Text  Link to Item
    • Ghany, Marc G., Robert Perrillo, Ruosha Li, Steven H. Belle, Harry L. A. Janssen, Norah A. Terrault, Margaret C. Shuhart, et al. “Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype.” Clin Gastroenterol Hepatol 13, no. 1 (January 2015): 183–92. https://doi.org/10.1016/j.cgh.2014.06.028.
       Full Text  Link to Item
    • Patel, Keyur, Katja S. Remlinger, Terence G. Walker, Peter Leitner, Joseph E. Lucas, Stephen D. Gardner, John G. McHutchison, Will Irving, and Indra Neil Guha. “Multiplex protein analysis to determine fibrosis stage and progression in patients with chronic hepatitis C.” Clin Gastroenterol Hepatol 12, no. 12 (December 2014): 2113-20.e1-3. https://doi.org/10.1016/j.cgh.2014.04.037.
       Full Text  Link to Item
    • Patel, Keyur, and Julius Wilder. “Fibroscan.” Clin Liver Dis (Hoboken) 4, no. 5 (November 2014): 97–101. https://doi.org/10.1002/cld.407.
       Full Text  Link to Item
    • Clark, Paul J., Alexander J. Thompson, Keyur Patel, Andrew J. Muir, and Michael L. Volk. “Trends in hepatitis C treatment uptake in the United States.” Hepatology 60, no. 2 (August 2014): 768–69. https://doi.org/10.1002/hep.27213.
       Full Text  Link to Item
    • Choi, Steve S., Lee C. Claridge, Ravi Jhaveri, Marzena Swiderska-Syn, Paul Clark, Ayako Suzuki, Thiago A. Pereira, et al. “Osteopontin is up-regulated in chronic hepatitis C and is associated with cellular permissiveness for hepatitis C virus replication.” Clin Sci (Lond) 126, no. 12 (June 2014): 845–55. https://doi.org/10.1042/CS20130473.
       Full Text  Link to Item
    • Patel, Keyur, and Nicholas A. Shackel. “Current status of fibrosis markers.” Curr Opin Gastroenterol 30, no. 3 (May 2014): 253–59. https://doi.org/10.1097/MOG.0000000000000059.
       Full Text  Link to Item
    • Cox, Natravis R., Keyur Patel, and Hans L. Tillmann. “A rationalized approach to the treatment of patients infected with hepatitis B.” Mol Diagn Ther 18, no. 2 (April 2014): 203–12. https://doi.org/10.1007/s40291-013-0072-1.
       Full Text  Link to Item
    • Lee, Tzu-Hao, Hans L. Tillmann, and Keyur Patel. “Individualized therapy for hepatitis C infection: focus on the interleukin-28B polymorphism in directing therapy.” Mol Diagn Ther 18, no. 1 (February 2014): 25–38. https://doi.org/10.1007/s40291-013-0053-4.
       Full Text  Link to Item
    • Wilder, Julius, and Keyur Patel. “The clinical utility of FibroScan(®) as a noninvasive diagnostic test for liver disease.” Med Devices (Auckl) 7 (2014): 107–14. https://doi.org/10.2147/MDER.S46943.
       Full Text  Open Access Copy  Link to Item
    • Tillmann, Hans L., and Keyur Patel. “Therapy of acute and fulminant hepatitis B.” Intervirology 57, no. 3–4 (2014): 181–88. https://doi.org/10.1159/000360939.
       Full Text  Link to Item
    • Tripuraneni, Vinay, Keyur Patel, Todd V. Brennan, and Lisa M. Ho. “Fulminant herpes simplex viral hepatitis: ultrasound and CT imaging appearance and a review of the imaging literature.” Clin Imaging 38, no. 2 (2014): 191–94. https://doi.org/10.1016/j.clinimag.2013.11.015.
       Full Text  Link to Item
    • Clark, P. J., A. Aghemo, E. Degasperi, E. Galmozzi, T. J. Urban, D. M. Vock, K. Patel, et al. “Inosine triphosphatase deficiency helps predict anaemia, anaemia management and response in chronic hepatitis C therapy.” J Viral Hepat 20, no. 12 (December 2013): 858–66. https://doi.org/10.1111/jvh.12113.
       Full Text  Link to Item
    • Shackel, N. A., K. Patel, and J. McHutchison. “Viral Hepatitis” 2 (August 29, 2013): 1173–90. https://doi.org/10.1016/B978-0-12-382227-7.00099-9.
       Full Text
    • Shackel, N. A., K. Patel, and J. McHutchison. “Cirrhosis” 2 (August 29, 2013): 935–54. https://doi.org/10.1016/B978-0-12-382227-7.00078-1.
       Full Text
    • Jacobson, Ira M., Stuart C. Gordon, Kris V. Kowdley, Eric M. Yoshida, Maribel Rodriguez-Torres, Mark S. Sulkowski, Mitchell L. Shiffman, et al. “Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options.” N Engl J Med 368, no. 20 (May 16, 2013): 1867–77. https://doi.org/10.1056/NEJMoa1214854.
       Full Text  Link to Item
    • Janssen, Harry L. A., Hendrik W. Reesink, Eric J. Lawitz, Stefan Zeuzem, Maribel Rodriguez-Torres, Keyur Patel, Adriaan J. van der Meer, et al. “Treatment of HCV infection by targeting microRNA.” N Engl J Med 368, no. 18 (May 2, 2013): 1685–94. https://doi.org/10.1056/NEJMoa1209026.
       Full Text  Link to Item
    • Chiba-Falek, Ornit, Colton Linnertz, John Guyton, Stephen D. Gardner, Allen D. Roses, Jeanette J. McCarthy, and Keyur Patel. “Pleiotropy and allelic heterogeneity in the TOMM40-APOE genomic region related to clinical and metabolic features of hepatitis C infection.” Hum Genet 131, no. 12 (December 2012): 1911–20. https://doi.org/10.1007/s00439-012-1220-0.
       Full Text  Link to Item
    • Thompson, A. J., and K. Patel. “New agents for the treatment of hepatitis C virus - Focus on telaprevir.” Virus Adaptation and Treatment 4, no. 1 (October 31, 2012): 75–84. https://doi.org/10.2147/VAAT.S12707.
       Full Text
    • Clark, P. J., A. J. Thompson, Q. Zhu, D. M. Vock, M. Zhu, K. Patel, S. A. Harrison, et al. “Erratum: The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis c infection (Digestive Diseases and Sciences (2012) 57 (2479)).” Digestive Diseases and Sciences 57, no. 9 (September 1, 2012): 2479. https://doi.org/10.1007/s10620-012-2309-y.
       Full Text
    • Clark, Paul J., Alexander J. Thompson, Qianqian Zhu, David M. Vock, Mingfu Zhu, Keyur Patel, Stephen A. Harrison, et al. “The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infection.” Dig Dis Sci 57, no. 8 (August 2012): 2213–21. https://doi.org/10.1007/s10620-012-2171-y.
       Full Text  Link to Item
    • Naggie, Susanna, Anu Osinusi, Antonios Katsounas, Richard Lempicki, Eva Herrmann, Alexander J. Thompson, Paul J. Clark, et al. “Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: impaired viral kinetics and therapeutic response.” Hepatology 56, no. 2 (August 2012): 444–54. https://doi.org/10.1002/hep.25647.
       Full Text  Link to Item
    • Tapper, Elliot B., Eric B. Cohen, Keyur Patel, Bruce Bacon, Stuart Gordon, Eric Lawitz, David Nelson, Imad A. Nasser, Tracy Challies, and Nezam Afdhal. “Levels of alanine aminotransferase confound use of transient elastography to diagnose fibrosis in patients with chronic hepatitis C virus infection.” Clin Gastroenterol Hepatol 10, no. 8 (August 2012): 932-937.e1. https://doi.org/10.1016/j.cgh.2012.01.015.
       Full Text  Link to Item
    • Clark, Paul J., Alexander J. Thompson, David M. Vock, Lisa E. Kratz, Adviye A. Tolun, Andrew J. Muir, John G. McHutchison, et al. “Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific manner.” Hepatology 56, no. 1 (July 2012): 49–56. https://doi.org/10.1002/hep.25631.
       Full Text  Link to Item
    • Lucas, Joseph E., J Will Thompson, Laura G. Dubois, Jeanette McCarthy, Hans Tillmann, Alexander Thompson, Norah Shire, et al. “Metaprotein expression modeling for label-free quantitative proteomics.” Bmc Bioinformatics 13 (May 4, 2012): 74. https://doi.org/10.1186/1471-2105-13-74.
       Full Text  Link to Item
    • Clark, P. J., A. J. Thompson, M. Zhu, D. M. Vock, Q. Zhu, D. Ge, K. Patel, et al. “Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response.” J Viral Hepat 19, no. 5 (May 2012): 332–40. https://doi.org/10.1111/j.1365-2893.2011.01553.x.
       Full Text  Link to Item
    • Jazwinski, A. B., A. J. Thompson, P. J. Clark, S. Naggie, H. L. Tillmann, and K. Patel. “Elevated serum CK18 levels in chronic hepatitis C patients are associated with advanced fibrosis but not steatosis.” J Viral Hepat 19, no. 4 (April 2012): 278–82. https://doi.org/10.1111/j.1365-2893.2011.01546.x.
       Full Text  Link to Item
    • Rowell, J., A. J. Thompson, J. R. Guyton, X. Q. Lao, J. G. McHutchison, J. J. McCarthy, and K. Patel. “Serum apolipoprotein C-III is independently associated with chronic hepatitis C infection and advanced fibrosis.” Hepatol Int 6, no. 2 (April 2012): 475–81. https://doi.org/10.1007/s12072-011-9291-x.
       Full Text  Link to Item
    • Glickman, Seth W., Sam Galhenage, Lindsay McNair, Zachry Barber, Keyur Patel, Kevin A. Schulman, and John G. McHutchison. “The potential influence of Internet-based social networking on the conduct of clinical research studies.” J Empir Res Hum Res Ethics 7, no. 1 (February 2012): 71–80. https://doi.org/10.1525/jer.2012.7.1.71.
       Full Text  Link to Item
    • Thompson, Alexander J., Paul J. Clark, Abanish Singh, Dongliang Ge, Jacques Fellay, Mingfu Zhu, Qianqian Zhu, et al. “Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients.” J Hepatol 56, no. 2 (February 2012): 313–19. https://doi.org/10.1016/j.jhep.2011.04.021.
       Full Text  Link to Item
    • Thompson, Alexander J., Keyur Patel, Wan-Long Chuang, Eric J. Lawitz, Maribel Rodriguez-Torres, Vinod K. Rustgi, Robert Flisiak, et al. “Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3.” Gut 61, no. 1 (January 2012): 128–34. https://doi.org/10.1136/gut.2010.236158.
       Full Text  Link to Item
    • Tillmann, Hans L., Keyur Patel, Andrew J. Muir, Cynthia D. Guy, Josephine H. Li, Xiang Qian Lao, Alexander Thompson, et al. “Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C.” J Hepatol 55, no. 6 (December 2011): 1195–1200. https://doi.org/10.1016/j.jhep.2011.03.015.
       Full Text  Link to Item
    • Patel, Keyur, Mireen Friedrich-Rust, Yoav Lurie, Mircea Grigorescu, Carol Stanciu, Chuan-Mo Lee, Eugene R. Schiff, et al. “FibroSURE and FibroScan in relation to treatment response in chronic hepatitis C virus.” World J Gastroenterol 17, no. 41 (November 7, 2011): 4581–89. https://doi.org/10.3748/wjg.v17.i41.4581.
       Full Text  Link to Item
    • Guha, Indra Neil, Robert P. Myers, Keyur Patel, and Jayant A. Talwalkar. “Biomarkers of liver fibrosis: what lies beneath the receiver operating characteristic curve?” Hepatology 54, no. 4 (October 2011): 1454–62. https://doi.org/10.1002/hep.24515.
       Full Text  Link to Item
    • Shah, Samir R., Keyur Patel, Patrick Marcellin, Graham R. Foster, Michael Manns, Shyam Kottilil, Letha Healey, et al. “Steatosis is an independent predictor of relapse following rapid virologic response in patients with HCV genotype 3.” Clin Gastroenterol Hepatol 9, no. 8 (August 2011): 688–93. https://doi.org/10.1016/j.cgh.2011.04.029.
       Full Text  Link to Item
    • Patel, Keyur, Alexander J. Thompson, Wan-Long Chuang, Chuan-Mo Lee, Chen-Yuan Peng, Ganesananthan Shanmuganathan, Satawat Thongsawat, et al. “Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients.” J Gastroenterol Hepatol 26, no. 7 (July 2011): 1182–88. https://doi.org/10.1111/j.1440-1746.2011.06722.x.
       Full Text  Link to Item
    • Patel, Keyur, Joseph E. Lucas, J Will Thompson, Laura G. Dubois, Hans L. Tillmann, Alexander J. Thompson, Diane Uzarski, et al. “High predictive accuracy of an unbiased proteomic profile for sustained virologic response in chronic hepatitis C patients.” Hepatology 53, no. 6 (June 2011): 1809–18. https://doi.org/10.1002/hep.24284.
       Full Text  Link to Item
    • Clark, Paul J., and Keyur Patel. “Noninvasive tools to assess liver disease.” Curr Opin Gastroenterol 27, no. 3 (May 2011): 210–16. https://doi.org/10.1097/MOG.0b013e328343e9a3.
       Full Text  Link to Item
    • Patel, K., R. Jhaveri, J. George, G. Qiang, C. Kenedi, K. Brown, C. Cates, et al. “Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C.” J Viral Hepat 18, no. 5 (May 2011): 331–37. https://doi.org/10.1111/j.1365-2893.2010.01310.x.
       Full Text  Link to Item
    • Thompson, Alexander J., Rosanna Santoro, Valeria Piazzolla, Paul J. Clark, Susanna Naggie, Hans L. Tillmann, Keyur Patel, et al. “Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR.” Hepatology 53, no. 2 (February 2011): 389–95. https://doi.org/10.1002/hep.24068.
       Full Text  Link to Item
    • Patel, S., V. Chauhan, J. Mandal, S. Shah, K. Patel, D. Saptarshi, K. Maheshwari, P. K. Jha, P. Kale, and P. Mathew. “Single-dose, Two-way Crossover, Bioequivalence Study of Mycophenolate Mofetil 500 mg Tablet Under Fasting Conditions in Healthy Male Subjects.” Clinical Therapeutics 33, no. 3 (2011): 378–90. https://doi.org/10.1016/j.clinthera.2011.04.003.
       Full Text
    • Cyr, Derek D., Joseph E. Lucas, J Will Thompson, Keyur Patel, Paul J. Clark, Alexander Thompson, Hans L. Tillmann, John G. McHutchison, M Arthur Moseley, and Jeanette J. McCarthy. “Characterization of serum proteins associated with IL28B genotype among patients with chronic hepatitis C.” Plos One 6, no. 7 (2011): e21854. https://doi.org/10.1371/journal.pone.0021854.
       Full Text  Link to Item
    • Patel, Keyur, Seng G. Lim, Chow W. Cheng, Eric Lawitz, Hans L. Tillmann, Narinder Chopra, Ralf Altmeyer, John C. R. Randle, and John G. McHutchison. “Open-label phase 1b pilot study to assess the antiviral efficacy of simvastatin combined with sertraline in chronic hepatitis C patients.” Antivir Ther 16, no. 8 (2011): 1341–46. https://doi.org/10.3851/IMP1898.
       Full Text  Link to Item
    • Thompson, Alexander J., Andrew J. Muir, Mark S. Sulkowski, Keyur Patel, Hans L. Tillmann, Paul J. Clark, Susanna Naggie, et al. “Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype.” Hepatology 52, no. 6 (December 2010): 2243–44. https://doi.org/10.1002/hep.23826.
       Full Text  Link to Item
    • Urban, Thomas J., Alexander J. Thompson, Shelton S. Bradrick, Jacques Fellay, Detlef Schuppan, Kenneth D. Cronin, Linda Hong, et al. “IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C.” Hepatology 52, no. 6 (December 2010): 1888–96. https://doi.org/10.1002/hep.23912.
       Full Text  Link to Item
    • Tillmann, Hans L., Alex J. Thompson, Keyur Patel, Manfred Wiese, Hannelore Tenckhoff, Hans D. Nischalke, Yuliya Lokhnygina, et al. “A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice.” Gastroenterology 139, no. 5 (November 2010): 1586-1592.e1. https://doi.org/10.1053/j.gastro.2010.07.005.
       Full Text  Link to Item
    • Naggie, Susanna, Keyur Patel, and John McHutchison. “Hepatitis C virus directly acting antivirals: current developments with NS3/4A HCV serine protease inhibitors.” J Antimicrob Chemother 65, no. 10 (October 2010): 2063–69. https://doi.org/10.1093/jac/dkq284.
       Full Text  Link to Item
    • Nelson, David R., Yves Benhamou, Wan-Long Chuang, Eric J. Lawitz, Maribel Rodriguez-Torres, Robert Flisiak, Jens W. F. Rasenack, et al. “Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 2 or 3.” Gastroenterology 139, no. 4 (October 2010): 1267–76. https://doi.org/10.1053/j.gastro.2010.06.062.
       Full Text  Link to Item
    • Bailey, Donald E., Julie Barroso, Andrew J. Muir, Richard Sloane, Jacqui Richmond, John McHutchison, Keyur Patel, Lawrence Landerman, and Merle H. Mishel. “Patients with chronic hepatitis C undergoing watchful waiting: Exploring trajectories of illness uncertainty and fatigue.” Res Nurs Health 33, no. 5 (October 2010): 465–73. https://doi.org/10.1002/nur.20397.
       Full Text  Link to Item
    • Thompson, Alexander J., Jacques Fellay, Keyur Patel, Hans L. Tillmann, Susanna Naggie, Dongliang Ge, Thomas J. Urban, et al. “Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia and decrease the need for ribavirin dose reduction.” Gastroenterology 139, no. 4 (October 2010): 1181–89. https://doi.org/10.1053/j.gastro.2010.06.016.
       Full Text  Link to Item
    • Harrison, Stephen A., Lorenzo Rossaro, Ke-Qin Hu, Keyur Patel, Hans Tillmann, Sandeep Dhaliwal, Dawn M. Torres, et al. “Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy.” Hepatology 52, no. 3 (September 2010): 864–74. https://doi.org/10.1002/hep.23787.
       Full Text  Link to Item
    • Mangia, Alessandra, Alexander J. Thompson, Rosanna Santoro, Valeria Piazzolla, Hans L. Tillmann, Keyur Patel, Kevin V. Shianna, et al. “An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response.” Gastroenterology 139, no. 3 (September 2010): 821-827.e1. https://doi.org/10.1053/j.gastro.2010.05.079.
       Full Text  Link to Item
    • Richmond, Jacqueline A., Donald E. Bailey, Keyur Patel, Janet A. Jezsik, Andrew Muir, Jr-Rung Lin, Shein-Chung Chow, Diane Uzarski, and John G. McHutchison. “The use of complementary and alternative medicine by patients with chronic hepatitis C.” Complement Ther Clin Pract 16, no. 3 (August 2010): 124–31. https://doi.org/10.1016/j.ctcp.2009.10.004.
       Full Text  Link to Item
    • Patel, K., H. L. Tillmann, and J. G. Mchutchison. “Hepatitis C,” July 22, 2010, 435–47. https://doi.org/10.1002/9781444314403.ch26.
       Full Text
    • Thompson, Alexander J., Andrew J. Muir, Mark S. Sulkowski, Dongliang Ge, Jacques Fellay, Kevin V. Shianna, Thomas Urban, et al. “Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus.” Gastroenterology 139, no. 1 (July 2010): 120-9.e18. https://doi.org/10.1053/j.gastro.2010.04.013.
       Full Text  Link to Item
    • Li, Josephine H., Xiang Qian Lao, Hans L. Tillmann, Jennifer Rowell, Keyur Patel, Alexander Thompson, Sunil Suchindran, et al. “Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection.” Hepatology 51, no. 6 (June 2010): 1904–11. https://doi.org/10.1002/hep.23592.
       Full Text  Link to Item
    • McCarthy, Jeanette J., Josephine H. Li, Alexander Thompson, Sunil Suchindran, Xiang Qian Lao, Keyur Patel, Hans L. Tillmann, Andrew J. Muir, and John G. McHutchison. “Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin.” Gastroenterology 138, no. 7 (June 2010): 2307–14. https://doi.org/10.1053/j.gastro.2010.02.009.
       Full Text  Link to Item
    • Patel, Keyur. “Noninvasive tools to assess liver disease.” Curr Opin Gastroenterol 26, no. 3 (May 2010): 227–33. https://doi.org/10.1097/MOG.0b013e3283383c68.
       Full Text  Link to Item
    • McHutchison, John, Zachary Goodman, Keyur Patel, Hala Makhlouf, Maribel Rodriguez-Torres, Mitchell Shiffman, Don Rockey, et al. “Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infection.” Gastroenterology 138, no. 4 (April 2010): 1365-1373.e2. https://doi.org/10.1053/j.gastro.2009.12.003.
       Full Text  Link to Item
    • Thompson, Alexander James, and Keyur Patel. “Antifibrotic therapies: will we ever get there?” Curr Gastroenterol Rep 12, no. 1 (February 2010): 23–29. https://doi.org/10.1007/s11894-009-0080-9.
       Full Text  Link to Item
    • Shackel, N. A., K. Patel, and J. McHutchison. “Diagnosis, Management and Disease Mechanisms of Hepatitis in the Era of Genomic Medicine,” December 1, 2009, 1375–89. https://doi.org/10.1016/B978-0-12-369420-1.00112-8.
       Full Text
    • Shackel, N. A., K. Patel, and J. McHutchison. “Cirrhosis in the era of genomic medicine,” December 1, 2009, 1138–54. https://doi.org/10.1016/B978-0-12-369420-1.00093-7.
       Full Text
    • Neumann, Avidan U., Vincent G. Bain, Eric M. Yoshida, Keyur Patel, Erik Pulkstenis, and G Mani Subramanian. “Early prediction of sustained virological response at day 3 of treatment with albinterferon-alpha-2b in patients with genotype 2/3 chronic hepatitis C.” Liver Int 29, no. 9 (October 2009): 1350–55. https://doi.org/10.1111/j.1478-3231.2009.02005.x.
       Full Text  Link to Item
    • Wiegand, Johannes, Keyur Patel, and Hans L. Tillmann. “Does hepatitis B surface antigen kinetics, including both decline and reaching a threshold, improve prediction of response?” Hepatology 50, no. 4 (October 2009): 1314. https://doi.org/10.1002/hep.23166.
       Full Text  Link to Item
    • Thompson, Alexander J. V., and Keyur Patel. “Antisense inhibitors, ribozymes, and siRNAs.” Clin Liver Dis 13, no. 3 (August 2009): 375–90. https://doi.org/10.1016/j.cld.2009.05.003.
       Full Text  Link to Item
    • Patel, K., Y. Benhamou, E. M. Yoshida, K. D. Kaita, S. Zeuzem, M. Torbenson, E. Pulkstenis, G. M. Subramanian, and J. G. McHutchison. “An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa-2b combination therapy for chronic hepatitis C.” J Viral Hepat 16, no. 3 (March 2009): 178–86. https://doi.org/10.1111/j.1365-2893.2008.01062.x.
       Full Text  Link to Item
    • Kaiser, Thorsten, Joachim Moessner, Keyur Patel, John G. McHutchison, and Hans L. Tillmann. “Life threatening liver disease during treatment with monoclonal antibodies.” Bmj 338 (February 18, 2009): b508. https://doi.org/10.1136/bmj.b508.
       Full Text  Link to Item
    • Tillmann, Hans L., Keyur Patel, and John G. McHutchison. “Role of growth factors and thrombopoietic agents in the treatment of chronic hepatitis C.” Curr Gastroenterol Rep 11, no. 1 (February 2009): 5–14. https://doi.org/10.1007/s11894-009-0002-x.
       Full Text  Link to Item
    • Tillmann, Hans, Keyur Patel, and John McHutchison. “Hepatitis B virus viral load and treatment decision.” Hepatology 49, no. 2 (February 2009): 699. https://doi.org/10.1002/hep.22755.
       Full Text  Link to Item
    • Thompson, Alex, Keyur Patel, Hans Tillman, and John G. McHutchison. “Directly acting antivirals for the treatment of patients with hepatitis C infection: a clinical development update addressing key future challenges.” J Hepatol 50, no. 1 (January 2009): 184–94. https://doi.org/10.1016/j.jhep.2008.10.011.
       Full Text  Link to Item
    • Srygley, F. D., and K. Patel. “Noninvasive assessment of liver fibrosis in chronic hepatitis C infection.” Current Hepatitis Reports 7, no. 4 (December 1, 2008): 164–72. https://doi.org/10.1007/s11901-008-0032-0.
       Full Text
    • Dev, Anouk T., Teresa L. Kauf, Amany Zekry, Keyur Patel, Karen Heller, Kevin A. Schulman, and John G. McHutchison. “Factors influencing the participation of gastroenterologists and hepatologists in clinical research.” Bmc Health Serv Res 8 (October 8, 2008): 208. https://doi.org/10.1186/1472-6963-8-208.
       Full Text  Link to Item
    • Canlas, Karen R., Brian M. Dobozi, Sauyu Lin, Alastair D. Smith, Don C. Rockey, Andrew J. Muir, Naurang M. Agrawal, Martin H. Poleski, Keyur Patel, and John G. McHutchison. “Using capsule endoscopy to identify GI tract lesions in cirrhotic patients with portal hypertension and chronic anemia.” J Clin Gastroenterol 42, no. 7 (August 2008): 844–48. https://doi.org/10.1097/MCG.0b013e318038d312.
       Full Text  Link to Item
    • Ward, C. L., A. Dev, S. Rigby, W. T. Symonds, K. Patel, A. Zekry, J. -. M. Pawlotsky, and J. G. McHutchison. “Interferon and ribavirin therapy does not select for resistance mutations in hepatitis C virus polymerase.” J Viral Hepat 15, no. 8 (August 2008): 571–77. https://doi.org/10.1111/j.1365-2893.2008.00980.x.
       Full Text  Link to Item
    • Bain, Vincent G., Kelly D. Kaita, Paul Marotta, Eric M. Yoshida, Mark G. Swain, Robert J. Bailey, Keyur Patel, et al. “Safety and antiviral activity of albinterferon alfa-2b dosed every four weeks in genotype 2/3 chronic hepatitis C patients.” Clin Gastroenterol Hepatol 6, no. 6 (June 2008): 701–6. https://doi.org/10.1016/j.cgh.2008.02.056.
       Full Text  Link to Item
    • Tillmann, Hans L., Keyur Patel, and John G. McHutchison. “GBV-C in HIV-HCV coinfection, low liver-related mortality but high overall mortality.” Gastroenterology 134, no. 7 (June 2008): 2191. https://doi.org/10.1053/j.gastro.2008.01.086.
       Full Text  Link to Item
    • McHutchison, J. G., K. Patel, E. R. Schiff, N. Gitlin, R. E. Mur, G. T. Everson, R. L. Carithers, et al. “Clinical trial: interferon alpha-2b continuous long-term therapy vs. repeated 24-week cycles for re-treating chronic hepatitis C.” Aliment Pharmacol Ther 27, no. 5 (March 1, 2008): 422–32. https://doi.org/10.1111/j.1365-2036.2007.03590.x.
       Full Text  Link to Item
    • Patel, Keyur, David R. Nelson, Don C. Rockey, Nezam H. Afdhal, Katie M. Smith, Esther Oh, Keith Hettinger, et al. “Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.” Clin Gastroenterol Hepatol 6, no. 2 (February 2008): 242–47. https://doi.org/10.1016/j.cgh.2007.11.009.
       Full Text  Link to Item
    • Jhaveri, Ravi, John McHutchison, Keyur Patel, Guan Qiang, and Anna Mae Diehl. “Specific polymorphisms in hepatitis C virus genotype 3 core protein associated with intracellular lipid accumulation.” J Infect Dis 197, no. 2 (January 15, 2008): 283–91. https://doi.org/10.1086/524846.
       Full Text  Link to Item
    • White, Ian R., Keyur Patel, William T. Symonds, Anouk Dev, Philip Griffin, Nikos Tsokanas, Mark Skehel, et al. “Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection.” J Transl Med 5 (July 11, 2007): 33. https://doi.org/10.1186/1479-5876-5-33.
       Full Text  Link to Item
    • Brady, C. W., J. G. McHutchison, and K. Patel. “Fibrosis markers in hepatitis C.” Current Hepatitis Reports 5, no. 3 (August 1, 2006): 86–93. https://doi.org/10.1007/s11901-006-0010-3.
       Full Text
    • Patel, Keyur. “Is compliance with antiviral therapy for chronic hepatitis C lower in intravenous drug users?” Nat Clin Pract Gastroenterol Hepatol 3, no. 7 (July 2006): 368–69. https://doi.org/10.1038/ncpgasthep0547.
       Full Text  Link to Item
    • Dev, Anouk, Keyur Patel, Andrew Conrad, Lawrence M. Blatt, and John G. McHutchison. “Relationship of smoking and fibrosis in patients with chronic hepatitis C.” Clin Gastroenterol Hepatol 4, no. 6 (June 2006): 797–801. https://doi.org/10.1016/j.cgh.2006.03.019.
       Full Text  Link to Item
    • Lim, Rebecca, Belinda Knight, Keyur Patel, John G. McHutchison, George C. Yeoh, and John K. Olynyk. “Antiproliferative effects of interferon alpha on hepatic progenitor cells in vitro and in vivo.” Hepatology 43, no. 5 (May 2006): 1074–83. https://doi.org/10.1002/hep.21170.
       Full Text  Link to Item
    • Patel, Keyur, Andrew J. Muir, and John G. McHutchison. “Diagnosis and treatment of chronic hepatitis C infection.” Bmj 332, no. 7548 (April 29, 2006): 1013–17. https://doi.org/10.1136/bmj.332.7548.1013.
       Full Text  Link to Item
    • McHutchison, John G., Ralf Bartenschlager, Keyur Patel, and Jean-Michel Pawlotsky. “The face of future hepatitis C antiviral drug development: recent biological and virologic advances and their translation to drug development and clinical practice.” J Hepatol 44, no. 2 (February 2006): 411–21. https://doi.org/10.1016/j.jhep.2005.12.001.
       Full Text  Link to Item
    • Patel, Keyur, Suzanne Norris, Lauralynn Lebeck, Anne Feng, Michael Clare, Stephen Pianko, Bernard Portmann, et al. “HLA class I allelic diversity and progression of fibrosis in patients with chronic hepatitis C.” Hepatology 43, no. 2 (February 2006): 241–49. https://doi.org/10.1002/hep.21040.
       Full Text  Link to Item
    • Powers, Kimberly A., Ruy M. Ribeiro, Keyur Patel, Stephen Pianko, Lisa Nyberg, Paul Pockros, Andrew J. Conrad, John McHutchison, and Alan S. Perelson. “Kinetics of hepatitis C virus reinfection after liver transplantation.” Liver Transpl 12, no. 2 (February 2006): 207–16. https://doi.org/10.1002/lt.20572.
       Full Text  Link to Item
    • McHutchison, John G., Keyur Patel, Paul Pockros, Lisa Nyberg, Stephen Pianko, Rosie Z. Yu, F Andrew Dorr, and T Jesse Kwoh. “A phase I trial of an antisense inhibitor of hepatitis C virus (ISIS 14803), administered to chronic hepatitis C patients.” J Hepatol 44, no. 1 (January 2006): 88–96. https://doi.org/10.1016/j.jhep.2005.09.009.
       Full Text  Link to Item
    • Patel, Keyur, and Don C. Rockey. “Clinical Utility of Biomarkers of Liver Fibrosis.” Gastroenterol Hepatol (N Y) 2, no. 1 (January 2006): 48–57.
       Link to Item
    • Patel, Keyur, Amany Zekry, and John G. McHutchison. “Steatosis and chronic hepatitis C virus infection: mechanisms and significance.” Clin Liver Dis 9, no. 3 (August 2005): 399–vi. https://doi.org/10.1016/j.cld.2005.05.007.
       Full Text  Link to Item
    • Condron, Steven L., Michael A. Heneghan, Keyur Patel, Anouk Dev, John G. McHutchison, and Andrew J. Muir. “Effect of donor age on survival of liver transplant recipients with hepatitis C virus infection.” Transplantation 80, no. 1 (July 15, 2005): 145–48. https://doi.org/10.1097/01.tp.0000164291.35925.7a.
       Full Text  Link to Item
    • Zekry, Amany, Keyur Patel, and John G. McHutchison. “Treatment of acute hepatitis C infection: more pieces of the puzzle?” J Hepatol 42, no. 3 (March 2005): 293–96. https://doi.org/10.1016/j.jhep.2004.12.012.
       Full Text  Link to Item
    • Rulyak, Stephen J., Sue C. Eng, Keyur Patel, John G. McHutchison, Stuart C. Gordon, and Kris V. Kowdley. “Relationships between hepatic iron content and virologic response in chronic hepatitis C patients treated with interferon and ribavirin.” Am J Gastroenterol 100, no. 2 (February 2005): 332–37. https://doi.org/10.1111/j.1572-0241.2005.41112.x.
       Full Text  Link to Item
    • Patel, Keyur, Jeff Albrecht, Erin Owens, Anouk Dev, Shanon Heaton, Stephen Pianko, Paul J. Pockros, Andrew Conrad, Lawrence M. Blatt, and John G. McHutchison. “The clinical utility of using Catrimox-14-treated whole blood in detecting hepatitis C virus RNA.” Antivir Ther 10, no. 4 (2005): 535–41.
       Link to Item
    • Patel, Keyur, Stuart C. Gordon, Ira Jacobson, Christophe Hézode, Esther Oh, Katie M. Smith, Jean-Michel Pawlotsky, and John G. McHutchison. “Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients.” J Hepatol 41, no. 6 (December 2004): 935–42. https://doi.org/10.1016/j.jhep.2004.08.008.
       Full Text  Link to Item
    • Zekry, Amany, Keyur Patel, Andrew Muir, and John G. McHutchison. “Tinkering and tailoring with HCV therapy: can we get away with less?” Hepatology 40, no. 6 (December 2004): 1249–51. https://doi.org/10.1002/hep.20513.
       Full Text  Link to Item
    • Dev, Anouk, Keyur Patel, and John G. McHutchison. “Hepatitis C and steatosis.” Clin Liver Dis 8, no. 4 (November 2004): 881–ix. https://doi.org/10.1016/j.cld.2004.06.007.
       Full Text  Link to Item
    • Patel, K., and J. G. McHurtchinson. “Current therapies for chronic hepatitis C.” Sendrom 16, no. 7 (July 1, 2004): 20–27.
    • Patel, Keyur, and John G. McHutchison. “Initial treatment for chronic hepatitis C: current therapies and their optimal dosing and duration.” Cleve Clin J Med 71 Suppl 3 (May 2004): S8-12. https://doi.org/10.3949/ccjm.71.suppl_3.s8.
       Full Text  Link to Item
    • Shatin, Deborah, Stephanie D. Schech, Keyur Patel, and John G. McHutchison. “Population-based hepatitis C surveillance and treatment in a national managed care organization.” Am J Manag Care 10, no. 4 (April 2004): 250–56.
       Link to Item
    • Patton, Heather M., Keyur Patel, Cynthia Behling, David Bylund, Lawrence M. Blatt, Marc Vallée, Shanon Heaton, Andrew Conrad, Paul J. Pockros, and John G. McHutchison. “The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients.” J Hepatol 40, no. 3 (March 2004): 484–90. https://doi.org/10.1016/j.jhep.2003.11.004.
       Full Text  Link to Item
    • Monto, Alexander, Keyur Patel, Alan Bostrom, Stephen Pianko, Paul Pockros, John G. McHutchison, and Teresa L. Wright. “Risks of a range of alcohol intake on hepatitis C-related fibrosis.” Hepatology 39, no. 3 (March 2004): 826–34. https://doi.org/10.1002/hep.20127.
       Full Text  Link to Item
    • Dev, Anouk, Keyur Patel, and John G. McHutchison. “New therapies for chronic hepatitis C virus infection.” Curr Gastroenterol Rep 6, no. 1 (February 2004): 77–86. https://doi.org/10.1007/s11894-004-0030-5.
       Full Text  Link to Item
    • Dev, A., K. Patel, and J. G. McHutchison. “Future treatment of hepatitis C: What's around the corner.” Infections in Medicine 21, no. 1 (January 1, 2004): 28–36.
    • Patel, K., and J. G. McHurtchinson. “Current therapies for chronic hepatitis C.” Sendrom 16, no. 7 (2004): 20–27.
    • Verbrugh, Henri A. “Selective decontamination of digestive tract in intensive care.” Lancet 362, no. 9401 (December 20, 2003): 2117–18. https://doi.org/10.1016/S0140-6736(03)15117-3.
       Full Text  Link to Item
    • Dev, Anouk, Keyur Patel, Andrew Muir, and John G. McHutchison. “Erythropoietin for ribavirin-induced anemia in hepatitis C: more answers but many more questions.” Am J Gastroenterol 98, no. 11 (November 2003): 2344–47. https://doi.org/10.1111/j.1572-0241.2003.08696.x.
       Full Text  Link to Item
    • Patel, Keyur, Anouk Dev, Andrew J. Muir, and John G. McHutchison. “Ribavirin as maintenance therapy for hepatitis C patients: an interim peacekeeper?” Hepatology 38, no. 1 (July 2003): 21–24. https://doi.org/10.1053/jhep.2003.50326.
       Full Text  Link to Item
    • Patel, Keyur, and John G. McHutchison. “Current therapies for chronic hepatitis C. Drug combination achieves sustained response in more than half of patients.” Postgrad Med 114, no. 1 (July 2003): 48–62. https://doi.org/10.3810/pgm.2003.07.1452.
       Full Text  Link to Item
    • Pockros, Paul J., Keyvr Patel, Christopher O’Brien, Myron Tong, Coleman Smith, Vinod Rustgi, Robert L. Carithers, John G. McHutchison, Elizabeth Olek, and Michael F. Debruin. “A multicenter study of recombinant human interleukin 12 for the treatment of chronic hepatitis C virus infection in patients nonresponsive to previous therapy.” Hepatology 37, no. 6 (June 2003): 1368–74. https://doi.org/10.1053/jhep.2003.50242.
       Full Text  Link to Item
    • Patel, K., A. Muir, J. G. McHutchison, and H. M. Patton. “A link between leptin and steatosis in chronic hepatitis C? Time to weigh up the fats.” Am J Gastroenterol 98, no. 5 (May 2003): 952–55. https://doi.org/10.1111/j.1572-0241.2003.07422.x.
       Full Text  Link to Item
    • Patel, Keyur, Andrew J. Muir, and John G. McHutchison. “Validation of a simple predictive model for the identification of mild hepatic fibrosis in chronic hepatitis C patients.” Hepatology 37, no. 5 (May 2003): 1222. https://doi.org/10.1053/jhep.2003.50159.
       Full Text  Link to Item
    • Thabut, Dominique, Marion Simon, Robert P. Myers, Djamila Messous, Vincent Thibault, Françoise Imbert-Bismut, and Thierry Poynard. “Noninvasive prediction of fibrosis in patients with chronic hepatitis C.” Hepatology 37, no. 5 (May 2003): 1220–21. https://doi.org/10.1053/jhep.2003.50109.
       Full Text  Link to Item
    • Patel, Keyur, Adrianne Lajoie, Shanon Heaton, Stephen Pianko, Cynthia A. Behling, David Bylund, Paul J. Pockros, Lawrence M. Blatt, Andrew Conrad, and John G. McHutchison. “Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C.” J Gastroenterol Hepatol 18, no. 3 (March 2003): 253–57. https://doi.org/10.1046/j.1440-1746.2003.02930.x.
       Full Text  Link to Item
    • Myers, R. P., K. Patel, S. Pianko, T. Poynard, and J. G. McHutchison. “The rate of fibrosis progression is an independent predictor of the response to antiviral therapy in chronic hepatitis C.” J Viral Hepat 10, no. 1 (January 2003): 16–22. https://doi.org/10.1046/j.1365-2893.2003.00387.x.
       Full Text  Link to Item
    • McHutchison, John G., and Keyur Patel. “Future therapy of hepatitis C.” Hepatology 36, no. 5 Suppl 1 (November 2002): S245–52. https://doi.org/10.1053/jhep.2002.36795.
       Full Text  Link to Item
    • McHutchison, John G., Michael Manns, Keyur Patel, Thierry Poynard, Karen L. Lindsay, Christian Trepo, Jules Dienstag, et al. “Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C.” Gastroenterology 123, no. 4 (October 2002): 1061–69. https://doi.org/10.1053/gast.2002.35950.
       Full Text  Link to Item
    • Reynolds, W. F., K. Patel, S. Pianko, L. M. Blatt, J. J. Nicholas, and J. G. McHutchison. “A genotypic association implicates myeloperoxidase in the progression of hepatic fibrosis in chronic hepatitis C virus infection.” Genes Immun 3, no. 6 (September 2002): 345–49. https://doi.org/10.1038/sj.gene.6363880.
       Full Text  Link to Item
    • Bouvier-Alias, Magali, Keyur Patel, Harel Dahari, Stéphanie Beaucourt, Patrick Larderie, Lawrence Blatt, Christophe Hezode, et al. “Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication.” Hepatology 36, no. 1 (July 2002): 211–18. https://doi.org/10.1053/jhep.2002.34130.
       Full Text  Link to Item
    • Pianko, Stephen, John G. McHutchison, Stuart C. Gordon, Shanon Heaton, Zachary D. Goodman, Keyur Patel, Cherise M. Cortese, Elizabeth M. Brunt, Bruce R. Bacon, and Lawrence M. Blatt. “Hepatic iron concentration does not influence response to therapy with interferon plus ribavirin in chronic HCV infection.” J Interferon Cytokine Res 22, no. 4 (April 2002): 483–89. https://doi.org/10.1089/10799900252952271.
       Full Text  Link to Item
    • McHutchison, John G., Thierry Poynard, Rafael Esteban-Mur, Gary L. Davis, Zachary D. Goodman, Joann Harvey, Mei-Hsiu Ling, et al. “Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin.” Hepatology 35, no. 3 (March 2002): 688–93. https://doi.org/10.1053/jhep.2002.31870.
       Full Text  Link to Item
    • Patel, K., and N. E. Hoffman. “The anatomical distribution of colorectal polyps at colonoscopy.” J Clin Gastroenterol 33, no. 3 (September 2001): 222–25. https://doi.org/10.1097/00004836-200109000-00011.
       Full Text  Link to Item
    • Patel, K., and J. McHutchison. “Peginterferon alpha-2b: a new approach to improving response in hepatitis C patients.” Expert Opin Pharmacother 2, no. 8 (August 2001): 1307–15. https://doi.org/10.1517/14656566.2.8.1307.
       Full Text  Link to Item
    • Olynyk, J. K., and K. Patel. “Perioperative management of a common disorder: Hereditary haemochromatosis.” Current Opinion in Anaesthesiology 13, no. 3 (January 1, 2000): 333–39. https://doi.org/10.1097/00001503-200006000-00018.
       Full Text
    • Suzuki, Ayako, and Keith Lindor. “Nonalcoholic Fatty Liver Disease.” Karnataka Medical Journal 73, no. 2 (n.d.).

  • Book Sections

    • Shackel, N. A., and K. Patel. “Viral hepatitis.” In Genomic and Precision Medicine: Infectious and Inflammatory Disease, 155–65, 2019. https://doi.org/10.1016/B978-0-12-801496-7.00011-3.
       Full Text
    • Tu, T., K. Patel, and N. A. Shackel. “Viral Hepatitis.” In Genomic and Precision Medicine: Primary Care: Third Edition, 317–40, 2017. https://doi.org/10.1016/B978-0-12-800685-6.00017-5.
       Full Text
    • Shackel, N. A., K. Patel, and J. McHutchison. “Cirrhosis.” In Genomic and Personalized Medicine, 935–54, 2012. https://doi.org/10.1016/B978-0-12-382227-7.00078-1.
       Full Text
    • Shackel, N. A., K. Patel, and J. McHutchison. “Viral Hepatitis.” In Genomic and Personalized Medicine, 1173–90, 2012. https://doi.org/10.1016/B978-0-12-382227-7.00099-9.
       Full Text
    • Tillmann, H. L., A. Thompson, and K. Patel. “State of the art treatment of hepatitis C.” In Hepatitis C and Liver Transplantation, 13–27, 2010.
    • Shackel, N. A., K. Patel, and J. McHutchison. “Cirrhosis in the Era of Genomic Medicine.” In Genomic and Personalized Medicine: V1-2, 1138–54, 2008. https://doi.org/10.1016/B978-0-12-369420-1.00093-7.
       Full Text
    • Shackel, N. A., K. Patel, and J. McHutchison. “Diagnosis, Management and Disease Mechanisms of Hepatitis in the Era of Genomic Medicine.” In Genomic and Personalized Medicine: V1-2, 1375–89, 2008. https://doi.org/10.1016/B978-0-12-369420-1.00112-8.
       Full Text

  • Conference Papers

    • Satapathy, Sanjaya K., Yu Jiang, Uchenna Agbim, Cen Wu, David E. Bernstein, Lewis W. Teperman, Satish K. Kedia, et al. “Posttransplant Outcome of Lean Compared With Obese Nonalcoholic Steatohepatitis in the United States: The Obesity Paradox.” In Liver Transpl, 26:68–79, 2020. https://doi.org/10.1002/lt.25672.
       Full Text  Link to Item
    • Cross, C. W., W. Zhaoyang, and K. Patel. “Advances in salt point management practices: Mitigating overhead corrosion with big data.” In Fuels and Petrochemicals Division 2017  Core Programming Area at the Aiche Annual Meeting, 2017-October:87–97, 2017.
    • Cross, C. W., W. Zhaoyang, and K. Patel. “Advances in salt point management practices: Mitigating overhead corrosion with big data.” In Separations Division 2017  Core Programming Area at the 2017 Aiche Annual Meeting, 1:144–54, 2017.

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.